Your cornea is the clear “window” at the front of the eye. Its skin-like surface (called the corneal epithelium) is constantly renewed by special repair cells that live in a narrow ring at the edge of the cornea where it meets the white of the eye. This ring is called the limbus, and the repair cells are called limbal stem cells.
Limbal Stem Cell Deficiency (LSCD) happens when there are not enough healthy limbal stem cells to keep the cornea’s surface smooth, clear, and stable. When these cells are damaged, lost, or too few:
the cornea cannot heal properly,
the surface breaks down over and over,
blood vessels grow into places they do not belong,
the surface changes from “corneal type” to “conjunctival type” (skin from the white part creeps over the clear window),
vision becomes blurred and sensitive to light,
the eye can feel sore, gritty, or constantly irritated.
In short, LSCD is a failure of the eye’s front-surface repair system.
Why the limbus matters (how LSCD begins)
The limbus houses a niche—a safe “home”—for stem cells. These cells divide slowly, produce daughter cells, and replace worn-out corneal surface cells. The niche also protects them from stress and inflammation. If chemical burns, severe inflammation, infections, surgery, radiation, or genetic problems injure this niche, the stem cells die or stop working. The cornea then gets covered by conjunctival cells (a process called conjunctivalization) and grows blood vessels (neovascularization). That makes the once-clear window cloudy.
Simple keywords used in this guide
Corneal epithelium: the clear skin on the cornea.
Limbus: the edge where clear cornea meets white sclera; home of stem cells.
Conjunctivalization: white-eye surface tissue creeping over the cornea.
Neovascularization: new, unwanted blood vessels invading the cornea.
Palisades of Vogt: tiny natural ridges at the limbus that mark the stem-cell zone; often lost in LSCD.
Persistent epithelial defect: a non-healing scratch/ulcer on the cornea.
Types of LSCD
By cause (etiology)
Congenital: present from birth because of a gene problem (for example, aniridia due to PAX6 gene changes, or certain ectodermal syndromes). The limbal stem cells never develop normally or are too few.
Acquired: develops later in life from injury, disease, or treatment (for example, chemical burns, Stevens–Johnson syndrome, autoimmune disease, chronic contact lens overuse, medication toxicity).
By extent
Partial LSCD: only a sector of the limbus is damaged. Healthy areas can still supply some cells. Symptoms may come and go and are milder at first.
Total LSCD: all or nearly all the limbus is damaged. The corneal surface is unstable everywhere, with severe symptoms and marked vision loss.
By side (laterality)
Unilateral: one eye only (common after a one-sided chemical injury).
Bilateral: both eyes (common in genetic, autoimmune, or medication-related causes).
By time course
Acute: follows a recent injury (for example, within days to weeks after a burn).
Chronic: long-standing, often due to repeated inflammation or long-term toxicity; surface becomes scarred and vascularized over months to years.
By pattern
Focal/Sectoral: small wedge or clock-hour segment of limbus involved.
Diffuse: widespread damage across many clock hours.
By severity (simple clinical staging idea)
Mild: symptoms with early staining and small areas of conjunctivalization; vision mostly good between flares.
Moderate: frequent breakdowns, visible new vessels, irregular surface; vision variably blurred.
Severe: total or near-total conjunctivalization, scarring, non-healing defects; vision markedly reduced.
Common causes of LSCD
Alkali chemical burns (e.g., lime, lye, ammonia)
Alkali penetrates quickly, destroys the limbal niche, and kills stem cells. Even brief exposure can cause deep damage.Acid chemical burns (e.g., battery acid)
Acids cause protein coagulation that can still burn the limbus and scar the surface.Stevens–Johnson syndrome / Toxic epidermal necrolysis
A severe immune reaction to infections or drugs that attacks skin and mucous membranes, including the ocular surface and limbus.Ocular cicatricial pemphigoid (mucous membrane pemphigoid)
A chronic autoimmune disease that causes scarring of the conjunctiva, shrinking the limbal niche over time.Chronic contact lens overuse or misfit
Long daily wear, poor hygiene, low-oxygen lenses, or tight lenses lead to low oxygen at the limbus, microtrauma, inflammation, and gradual stem-cell loss.Preservative toxicity (especially benzalkonium chloride)
Frequent use of drop bottles with strong preservatives (e.g., for glaucoma) irritates and inflames the limbus, slowly damaging stem cells.Multiple ocular surgeries near the limbus
Repeated pterygium surgeries, glaucoma filtering surgeries, tumor excisions, or cryotherapy can remove or scar the limbal stem-cell region.Radiation therapy to the orbit or eyelids
Ionizing radiation damages dividing cells and their niche; later the surface fails to renew.Cryotherapy or excessive cautery at the limbus
Intense cold or heat applied during procedures can unintentionally injure the stem-cell zone.Severe infectious keratitis (bacterial, fungal, acanthamoeba)
Deep corneal infections and the inflammation around them can spill into the limbus and wipe out stem cells.Herpes simplex or herpes zoster eye disease
These viruses inflame and disrupt corneal nerves and the limbal region, impairing healing and stability.Severe allergic eye disease (vernal or atopic keratoconjunctivitis)
Long-term itching, rubbing, and inflammatory chemicals damage the limbus and cornea.Aniridia (congenital PAX6 mutation)
The limbal niche is underdeveloped from birth; stem cells do not maintain the surface well, worsening with age.Ectodermal dysplasia syndromes (e.g., EEC, KID syndrome)
Genetic conditions affecting skin, hair, nails, and ocular surface cause poor limbal stem-cell health.Vitamin A deficiency (severe, prolonged)
Vitamin A is crucial for surface health. Without it, the conjunctiva and cornea keratinize and stem cells fail.Neurotrophic keratopathy (loss of corneal sensation)
Poor corneal nerve supply (after herpes, surgery, diabetes, or neurosurgery) prevents normal healing and destabilizes the surface.Chronic mechanical irritation (trichiasis, entropion, exposed sutures)
Lashes or lids constantly rubbing the limbus slowly destroy the niche.Toxic environmental exposure (solvents, pesticides, smoke, dust)
Repeated surface toxicity and inflammation harm the limbal area.Iatrogenic LSCD after limbal tissue harvest or repeat pterygium excision
Taking limbal tissue for grafts or too-aggressive removal of a pterygium can leave the donor limbus deficient.Antimetabolite exposure (e.g., mitomycin-C, 5-fluorouracil) around the limbus
These agents reduce scarring but can harm stem cells when used repeatedly or at high dose near the limbus.
Symptoms
Blurry or fluctuating vision
The surface is rough and unstable, so light does not focus cleanly; vision varies during the day.Light sensitivity (photophobia)
The injured surface and inflamed tissues make bright light feel painful or dazzling.Redness
Extra blood flow and new vessels grow in response to chronic irritation.Grittiness or foreign-body sensation
Rough, shed cells on the surface feel like sand in the eye.Burning or stinging
Inflamed nerves in the cornea create a constant burning sensation.Tearing (watering eyes)
Reflex tears try to protect the irritated surface, but they rarely fix the problem.Dryness
Tear quality and distribution are poor on an irregular surface, so the eye still feels dry even when watery.Pain or soreness
Recurrent surface breakdown exposes sensitive nerve endings.Frequent erosions or non-healing “scratches”
The epithelium peels off easily and takes a long time to regrow.Stringy or mucus discharge
Conjunctival cells on the cornea make more mucus than normal corneal cells.Glare and halos
An uneven surface scatters light, especially at night.Poor contrast and “foggy” vision
Even if letters are visible, everything looks washed out.Contact lens intolerance
Lenses feel uncomfortable and worsen redness or pain.Recurrent infections
Defective surface defense increases the risk of microbial keratitis.Slow recovery after minor injuries or surgery
The cornea takes unusually long to heal from routine events.
Diagnostic tests
A) Physical exam–based tests (seen at the slit lamp)
Slit-lamp biomicroscopy of the limbus and cornea
The eye doctor examines the limbus and corneal surface with a microscope. In LSCD they may see loss of the palisades of Vogt, a dull or irregular surface, and creeping conjunctiva.Fluorescein dye staining pattern
A safe orange dye highlights damaged areas under blue light. In LSCD, staining is patchy, often in a whorl pattern, and shows persistent epithelial defects.Lissamine green or rose bengal staining
These dyes stick to unhealthy or mucus-coated cells. Staining on the cornea suggests conjunctival cells have moved onto the cornea.Assessment of corneal neovascularization
The doctor maps new blood vessels that have invaded the normally clear cornea—common in long-standing LSCD.Evaluation of the palisades of Vogt
The tiny limbal ridges are often absent or blurred in LSCD, which signals damage to the stem-cell area.
B) Manual/bedside functional tests
Cochet–Bonnet corneal esthesiometry (corneal sensitivity)
A thin nylon filament gently touches the cornea to see how sensitive it is. Reduced feeling suggests nerve damage that often travels with surface instability.Schirmer test (tear quantity)
A small strip of paper sits under the lower lid for a few minutes to measure tearing. Low values mean dry eye is also present, which worsens LSCD.Tear film break-up time (TBUT) after fluorescein
The doctor times how quickly the tear film breaks into dry spots. Fast break-up means poor tear stability on a rough surface.Lid eversion and meibomian gland expression
Turning the lid reveals scarring, papillae, or lashes rubbing the cornea; gently pressing glands checks oil quality. Lid disease can aggravate LSCD.
C) Laboratory and pathological tests
Impression cytology (cell-type test) with PAS stain
A tiny filter paper touches the cornea to pick up surface cells. Under a microscope, goblet cells (conjunctival type) on the cornea confirm conjunctivalization.Immunocytochemistry for cytokeratin profile
Corneal cells normally express K3/K12; conjunctival cells express K7/K13/K19. A “conjunctival” profile on the cornea supports LSCD.Tear osmolarity
Measures saltiness of tears. High osmolarity shows tear film stress, which commonly accompanies LSCD and explains irritation.Tear MMP-9 (e.g., InflammaDry)
A quick test for an inflammation enzyme. Positive results indicate active surface inflammation that destabilizes healing.Microbiologic culture or PCR from a persistent defect
If the non-healing area looks infected, swabs or scrapings check for bacteria, fungi, or amoeba so that infection is not missed.
D) Electrodiagnostic tests (not specific to LSCD, but helpful in difficult cases)
Visual evoked potential (VEP)
Measures electrical signals from the brain’s visual cortex after light flashes. Used to confirm that blurred vision is from the front of the eye (surface problem) rather than from the optic nerve or brain.Full-field electroretinography (ERG)
Measures the retina’s electrical response to light. A normal ERG with poor vision pushes the doctor to look again at the cornea/ocular surface for the cause.
E) Imaging tests
In vivo confocal microscopy (IVCM)
A special microscope images living cells of the cornea and limbus at near-histology detail. In LSCD, it shows loss of limbal architecture, abnormal basal cells, nerve loss, and invading conjunctival-type cells.Anterior segment optical coherence tomography (AS-OCT)
Like an ultrasound with light. It shows a cross-section of the limbus and cornea. In LSCD, the epithelial layer is irregular, and the limbal anatomy is altered.OCT angiography of the anterior segment (AS-OCTA)
Maps blood flow without dye. It highlights new vessels invading the cornea and limbus.Corneal topography/tomography (Placido or Scheimpflug) with pachymetry
Creates maps of corneal shape and thickness. Irregular astigmatism and surface roughness patterns support the diagnosis and help track change over time.
Non-pharmacological treatments
Education and trigger avoidance: Learn what harms limbal cells (preservatives, overnight contacts, rubbing). Purpose: stop ongoing damage. Mechanism: removing toxic or mechanical stress lets remaining stem cells recover.
Immediate stop or strict limits on contact lens wear: Especially after long over-wear. Purpose: remove friction and hypoxia. Mechanism: reduces rubbing and increases oxygen to the limbus.
Warm compresses + lid hygiene: Daily heat and gentle scrubs. Purpose: treat meibomian gland dysfunction. Mechanism: melts thick oils, improves tear film stability, reduces inflammation bathing the limbus.
In-office meibomian gland expression: Manual clearing by the clinician. Purpose: restore oil flow. Mechanism: squeezes out stagnant secretions that irritate the ocular surface.
Thermal pulsation (e.g., LipiFlow): Controlled heat and pressure device. Purpose: long-lasting MGD relief. Mechanism: liquefies and evacuates blocked oil.
Intense pulsed light (IPL) to lids: Light pulses reduce lid inflammation. Purpose: calm vascular and Demodex-related MGD. Mechanism: reduces abnormal blood vessels and mites that fuel inflammation.
Blink training and screen-time hygiene: 20-20-20 rule; purposeful complete blinks. Purpose: stabilize tears. Mechanism: renews tear film and spreads oils evenly.
Humidifier and environmental control: Add moisture at home/office; avoid fans and direct AC. Purpose: reduce evaporation stress. Mechanism: more ambient humidity = slower tear break-up.
Moisture-chamber glasses or goggles: Side-shielded eyewear. Purpose: protect surface outdoors or in air-con. Mechanism: creates a micro-humid environment around the eye.
UV-blocking sunglasses and wide-brim hat: Purpose: reduce light sensitivity and UV damage. Mechanism: less UV-induced inflammation.
Nighttime eyelid taping/eye shields: For exposure during sleep. Purpose: prevent drying. Mechanism: keeps lids closed and tears in place.
CPAP leak management: Adjust mask fit or use eye shields. Purpose: stop nocturnal air jets on the eye. Mechanism: removes dehydrating airflow.
Short-term protective patching (as advised): Purpose: rest a non-healing defect. Mechanism: reduces friction from blinking.
Bandage soft contact lens (therapeutic): Special high-oxygen lens fitted by a clinician. Purpose: shield abrasions/defects. Mechanism: creates a smooth, protective surface to help epithelial cells grow.
Scleral lens / PROSE device: Large lens vaulting the cornea and filled with sterile saline. Purpose: optical rehabilitation and pain relief. Mechanism: bathes the cornea in liquid all day and masks surface irregularity, often transforming vision in partial LSCD.
Punctal plugs (collagen or silicone): Close tear drains. Purpose: keep natural tears longer. Mechanism: raises tear volume without medication.
Protective eyewear at work and home: Goggles for chemicals, grinding, or cooking splatter. Purpose: prevent re-injury. Mechanism: physical barrier.
Avoid preserved drops and solutions: Switch to preservative-free where possible. Purpose: reduce toxicity to limbal cells. Mechanism: removes BAK exposure.
Allergy control without rubbing: Cold compresses and gentle dabbing instead of rubbing. Purpose: reduce friction. Mechanism: limits mechanical trauma to the limbus.
Diet, hydration, and general health habits: Adequate water, sleep, and balanced diet. Purpose: support healing. Mechanism: improves tear quality and immune balance (see supplement section below).
Drug treatments
Always follow your ophthalmologist’s exact plan; doses below are typical ranges, not personal medical advice.
Preservative-free artificial tears/gel (lubricant):
Class: ocular lubricant. Dose/time: 1–2 drops, 4–8×/day; gels/ointment at bedtime. Purpose: reduce friction and dilute inflammatory molecules. Mechanism: forms a smooth layer over the cornea. Side effects: temporary blur; very rare allergy.Vitamin A ointment at night:
Class: epithelial support. Dose: thin ribbon nightly. Purpose: nourishes surface cells. Mechanism: supports mucin and epithelial differentiation. Side effects: blur after application; rare irritation.Topical corticosteroid (e.g., loteprednol 0.2–0.5%):
Class: anti-inflammatory. Dose: 2–4×/day for 1–2 weeks, then taper. Purpose: calm inflammation that blocks healing. Mechanism: suppresses cytokines and vessel growth. Side effects: eye-pressure rise, cataract risk, infection masking—needs monitoring.Topical cyclosporine A (0.05–0.1%):
Class: calcineurin inhibitor (immunomodulator). Dose: 1 drop twice daily; effects after 4–8 weeks. Purpose: steroid-sparing control of surface inflammation. Mechanism: reduces T-cell activation and inflammatory tear chemistry. Side effects: burning on instillation; rare infection risk.Topical lifitegrast 5% (off-label in LSCD):
Class: LFA-1 antagonist (immunomodulator). Dose: 1 drop twice daily. Purpose: further reduces inflammatory cell binding. Mechanism: blocks LFA-1/ICAM-1 interaction. Side effects: dysgeusia (funny taste), irritation.Autologous serum tears (20–100%):
Class: biologic tear substitute. Dose: 6–8×/day (kept refrigerated). Purpose: provide growth factors, vitamins, and anti-inflammatory proteins naturally found in tears. Mechanism: delivers EGF, fibronectin, vitamin A, and other healing cues. Side effects: contamination risk if mishandled; cost/logistics.Platelet-rich plasma (PRP/PRGF) eyedrops:
Class: biologic. Dose: similar to serum tears. Purpose: stronger concentration of growth factors. Mechanism: platelets release PDGF, TGF-β, VEGF (beneficial at controlled levels) to drive epithelial repair. Side effects: similar to serum; transient irritation.Topical antibiotic (e.g., moxifloxacin) when defects present:
Class: antibacterial. Dose: 4×/day while the surface is open. Purpose: prevent infection of a non-healing defect. Mechanism: kills bacteria. Side effects: irritation; rare allergy.Oral doxycycline 50–100 mg once or twice daily (time-limited):
Class: tetracycline antibiotic with anti-inflammatory action. Purpose: treat MMP-driven breakdown and MGD. Mechanism: inhibits matrix metalloproteinases and reduces lid inflammation. Side effects: photosensitivity, stomach upset; avoid in pregnancy/children.Topical N-acetylcysteine 5–10% (compounded):
Class: mucolytic/anti-filamentary. Dose: 3–4×/day. Purpose: dissolve mucus filaments and reduce friction. Mechanism: breaks disulfide bonds in mucins. Side effects: stinging; rare allergy.
Dietary, molecular, and supportive supplements
Discuss supplements with your clinician, especially if pregnant, on blood thinners, or with liver/kidney disease.
Omega-3s (EPA+DHA) 1,000–2,000 mg/day: Anti-inflammatory; improves tear oil quality by shifting lipid mediators.
Gamma-linolenic acid (GLA) 240–300 mg/day (evening primrose/borage): Supports anti-inflammatory prostaglandins; helps evaporative dryness.
Vitamin A 2,500–5,000 IU/day (avoid high doses in pregnancy): Epithelial health; regulates mucin and differentiation.
Vitamin D3 1,000–2,000 IU/day (or per level): Immune modulation; may reduce ocular surface inflammation.
Vitamin C 500–1,000 mg/day: Collagen synthesis and antioxidant protection; supports wound healing.
Vitamin E 200 IU/day: Antioxidant synergy with vitamin C; protects cell membranes.
Zinc 10–20 mg/day: Cofactor for healing enzymes; supports epithelial repair.
Selenium 55–100 mcg/day: Antioxidant enzyme cofactor; reduces oxidative stress.
Magnesium 200–300 mg/day (night): Calms inflammation and supports nerve health.
Curcumin 500–1,000 mg/day with food: Down-regulates NF-κB; may lower chronic surface inflammation.
N-acetylcysteine (oral) 600 mg 1–2×/day: Systemic antioxidant and mucolytic; complements topical NAC.
Hyaluronic acid (oral) 120–240 mg/day: May improve tissue hydration; pairs with topical HA tears if prescribed.
L-carnitine 500–1,000 mg/day: Mitochondrial support; may help neuropathic discomfort.
Probiotics (≥10 billion CFU/day): Gut–immune axis support; may reduce systemic inflammatory tone.
Lutein 10 mg + Zeaxanthin 2 mg/day: Antioxidants that may aid ocular health overall; not specific to LSCD but supportive.
Regenerative drugs
These require specialist supervision and lab monitoring.
Oral cyclosporine (≈3–5 mg/kg/day in divided doses):
Function: prevent immune rejection after donor stem-cell graft; calm severe inflammation. Mechanism: calcineurin inhibition blocks T-cell activation.Tacrolimus (oral 0.05–0.1 mg/kg/day; sometimes topical 0.02–0.1% ointment to lids):
Function: alternative/adjunct to cyclosporine. Mechanism: calcineurin inhibition similar to cyclosporine, often better tolerated.Mycophenolate mofetil (1 g twice daily):
Function: steroid-sparing systemic immunosuppression. Mechanism: blocks purine synthesis in lymphocytes, reducing rejection risk.Prednisone (e.g., 0.5–1 mg/kg/day then taper):
Function: acute control of severe inflammation or early rejection. Mechanism: broad anti-inflammatory gene regulation.Rituximab (IV, per protocol in autoimmune cicatrizing disease):
Function: treats hard-to-control ocular cicatricial pemphigoid/autoimmune drivers. Mechanism: depletes CD20+ B cells.Cenegermin (recombinant human nerve growth factor) eye drops, 6×/day for 8 weeks:
Function: for co-existing neurotrophic keratopathy; improves corneal nerve health and epithelial healing. Mechanism: binds TrkA and p75 receptors, promoting nerve regeneration.
Surgeries
Amniotic membrane transplantation (AMT): A biologic “bandage” is placed on the cornea (sutured or as a ring device like PROKERA). Why: quiets inflammation, provides growth factors, and speeds epithelial healing in partial LSCD or acute injuries.
Simple limbal epithelial transplantation (SLET): Tiny limbal tissue pieces taken from the healthy eye (or a donor) are dotted onto an amniotic membrane over the scarred cornea. Why: the small biopsies expand into a new limbal layer with less risk to the donor eye.
Conjunctival–limbal autograft (CLAU): A larger limbal strip from the patient’s healthy eye is transplanted to the diseased eye. Why: powerful option for unilateral LSCD when the fellow eye is normal.
Cultivated limbal epithelial transplantation (CLET): A small limbal biopsy is grown in a lab to form a sheet of corneal epithelium, then transplanted. Why: treats bilateral or severe cases while minimizing donor damage.
Keratolimbal allograft (KLAL) / living-related CLAL: Limbal tissue from a cadaver or a living relative is grafted. Why: used when both eyes are affected or no autograft is possible; requires systemic immunosuppression to prevent rejection.
(Note: penetrating keratoplasty alone usually fails in LSCD because the surface cannot maintain a clear graft without restoring limbal stem cells first.)
Prevention tips (what you can do)
Wear proper eye protection for chemicals, heat, grinding, and yard work.
Avoid overnight or extended contact-lens wear unless specifically advised.
Use preservative-free drops and lens care systems whenever possible.
Do not rub your eyes; treat allergy and itch promptly.
Keep up lid hygiene to control blepharitis/MGD.
Manage systemic diseases (autoimmune disorders, vitamin A deficiency, diabetes).
UV protection outdoors (sunglasses + hat).
Humidify dry rooms, especially with AC or heaters on.
Get regular eye exams if you use chronic eyedrops (glaucoma meds, MMC) or have had surface surgery.
Learn and practice the 20-20-20 rule and full blinks during screens.
When to see a doctor
Seek urgent care now if you have a chemical splash, sudden severe pain, light sensitivity, non-healing scratch, discharge, or vision dropping over hours to days.
Book a prompt visit (days–weeks) if you notice increasing redness, worsening contact-lens intolerance, frequent erosions, or new blood vessels creeping onto the cornea.
Regular follow-up is essential after any limbal surgery or if you are on steroid or immunosuppressive therapy.
What to eat and what to avoid
Eat oily fish (salmon, sardines) 2–3×/week for natural omega-3s.
Eat colorful vegetables and fruit (leafy greens, carrots, citrus) for antioxidants and vitamin A precursors.
Eat nuts and seeds (walnut, flaxseed, chia) to support tear lipids.
Eat lean proteins and legumes to provide building blocks for healing.
Drink enough water; steady hydration supports tear volume.
Avoid smoking and second-hand smoke—major surface irritants.
Avoid very dry, windy dining spaces (sit away from fans/vents).
Avoid excessive alcohol (dehydrates and worsens inflammation).
Avoid ultra-processed, high-sugar foods that fuel inflammation.
Avoid supplements or herbal remedies that thin blood before surgery unless your surgeon approves.
Frequently asked questions
1) Can LSCD get better on its own?
Mild or partial cases can improve with strict avoidance of triggers, aggressive lubrication, and device-based care (like scleral lenses). Severe cases usually need surgical stem-cell restoration.
2) Is LSCD the same as dry eye?
No. Dry eye often co-exists and worsens symptoms, but LSCD is a stem-cell failure problem. Treating dryness helps, but restoring limbal function is key in moderate–severe disease.
3) Why do blood vessels grow onto my cornea?
When limbal cells fail, the cornea “turns into” conjunctiva. Conjunctiva naturally has vessels, so they creep in as part of the healing attempt—unfortunately this clouds vision.
4) Will glasses fix the blur?
Glasses can’t smooth an irregular, scarred surface. Scleral lenses often help dramatically by masking irregularity. Surgery may be needed if stem cells are largely lost.
5) Are steroids dangerous?
They’re powerful and useful short-term, but they can raise eye pressure and increase infection risk. Your doctor monitors this and tapers carefully.
6) What is the difference between SLET and CLET?
SLET uses tiny limbal chips placed directly on your eye; CLET grows cells in a lab first and then transfers a cell sheet. CLET is handy when both eyes are affected and donor tissue must be minimized.
7) If both eyes are bad, where do the new stem cells come from?
From a cadaver donor (KLAL) or a living related donor (lr-CLAL). These procedures need systemic immunosuppression to protect the graft.
8) Can I keep wearing contact lenses?
Often you’ll stop standard lenses; later, scleral lenses fitted by a specialist may become your main optical correction and protection.
9) Do serum or PRP drops really help?
Many patients feel better and heal faster because these drops contain growth factors and vitamins naturally present in healthy tears.
10) How long does it take to see improvement?
Comfort can improve in days to weeks with lubricants and device therapy; biologic drops may help within weeks. Surgical recovery and stabilization take months.
11) Is LSCD painful?
It can be, especially when the surface is raw or when filaments form. Bandage or scleral lenses, plus the right drops, usually relieve pain while healing proceeds.
12) Will a corneal transplant alone fix LSCD?
Usually not. Without stem cells, a corneal graft fails or quickly becomes opaque. Stem-cell restoration must come first or be combined with keratoplasty when appropriate.
13) Are there risks to immunosuppressive medicines?
Yes—high blood pressure, kidney issues, increased infection risk, and lab abnormalities are possible. That’s why they’re used only when needed and with careful monitoring.
14) What happens if I ignore LSCD?
Chronic pain, scarring, infections, and permanent vision loss are possible. Early evaluation prevents many of these outcomes.
15) What should I bring to my appointment?
A list of all drops and systemic medicines, your lens solutions, old eye records, and a history of exposures (chemicals, surgeries, radiation). Photos of the bottles help.
Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.
The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members
Last Updated: August 10, 2025.
